It's in my nature to always question instead of follow. That doesn't mean I'm negative, in fact, I'm quite optimistic about this investment, long term. I don't have a timeline, as this investment can't break me, but it could "make me" if it panned out. It's a calculated swing for the fences that represents a good gamble IMO.

What I don't like is the missed deadlines. If you miss deadlines in my business, you better have a good reason for doing so. Time kills deals and time costs money. If you consistently miss deadlines, I'm looking for somebody else who can do the job. I have investments in a couple of other biotechs, and they don't make claims they can't back up. Of course their CEO's are seasoned professionals in the field, so they understand what it takes to go through the trials and anticipate bumps in the road on the path to FDA approval. They also have the good fortune of having ample cash on hand and trading on NASDAQ, so they don't have to constantly pump. I'm hoping the cancer data pushes us on that exchange in 2021 because I do believe that will change the way we operate.